• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Beam Diagnostics, Excella Team Up On Alcohol Relapse App

Share:

August 27, 2019

The provider-facing technology is expected to help predict when a person is drinking again.

Beam Diagnostics is teaming up with tech company Excella to create an app that detects relapse in alcohol use disorder. The technology will specifically be targeted at helping providers predict when a patient might be struggling.

“Beacon was created to improve the lives of those suffering from alcohol misuse and to help prevent alcohol use disorder from going undiagnosed,” Dr. Sarah Snider, CEO of Beam, said in a statement. “Our partnership with Excella will help us create a user-friendly app to address the widespread challenge of substance abuse in our communities. Our combined forces with the students from Excella’s Extension Center will package advanced technology that can be easily integrated into any clinic or hospital.”

As part of the deal, students from Virginia Tech will be working with engineers from Excella on the project.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

WHY IT MATTERS

According to the CDC, excessive alcohol use leads to about 88,000 deaths in the U.S. a year. The agency said that, in the short term, excessive alcohol use can lead to injuries such as falls, burns or drowning. It can also lead to alcohol poisoning and violence. In the longer term, it can increase a person’s chances of developing certain kinds of cancers and lead to high blood pressure, heart disease and stroke.

THE LARGER TREND

Several digital health companies are working on technologies to help patients overcome alcohol use disorder. In November, digital therapeutic company Pear Therapeutics commercially launched its FDA-cleared product reSET for substance use disorder.

Others have taken a more consumer-driven approach. Hayver and Sobercoin use cryptocurrency as an incentive for users to cut back on drinking.

Not all of these platforms have been success stories. For example, in January New York City-based Annum Health, a digital health startup focused on using digital health tools to curb alcohol use, closed its doors due to financial circumstances.

Date: August 27, 2019

Source: MobiHealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Better Buy: Johnson & Johnson Vs. Eli LillyBetter Buy: Johnson & Johnson Vs. Eli Lilly
  • Medicxi Combines Six Portfolio Companies with $100M to Launch Alys PharmaMedicxi Combines Six Portfolio Companies with $100M to Launch Alys Pharma
  • Redox Launches Rapid Deployment Telehealth Model for Providers to Go-Live in Less Than 2 WeeksRedox Launches Rapid Deployment Telehealth Model for Providers to Go-Live in Less Than 2 Weeks
  • Healthy.io Acquires Fellow Smartphone Urinalysis Startup Inui HealthHealthy.io Acquires Fellow Smartphone Urinalysis Startup Inui Health
  • Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.
  • Bowman Acquires H2H Geoscience Engineering, Expands Benefit of Transportation Infrastructure SpendingBowman Acquires H2H Geoscience Engineering, Expands Benefit of Transportation Infrastructure Spending
  • New Features for Facebook Users Encourage Private Mental Health Conversations between FriendsNew Features for Facebook Users Encourage Private Mental Health Conversations between Friends
  • IBM Business Partner Evanston Technology Partners & Cylera Announce New Solution to Help Hospitals Manage & Protect Ventilators & Other Critical Medical Devices in the Age of COVID-19IBM Business Partner Evanston Technology Partners & Cylera Announce New Solution to Help Hospitals Manage & Protect Ventilators & Other Critical Medical Devices in the Age of COVID-19

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications